Global Spine Biologics Market: Size, Trends, Industry Share and Forecast, 2016 2024 – Digital Journal

Spine biologics is a treatment that is used during the spine fusion surgery for the treatment of spinal deformities that include spinal cord injuries, trauma, degenerative disc disease, and tumors.

This press release was orginally distributed by SBWire

Sarasota, FL -- (SBWIRE) -- 05/31/2017 -- Zion Market Research, the market research group announced the analysis report titled "Spine Biologics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 20162024"

Global Spine Biologics Market: Overview

Spine biologics is a treatment that is used during the spine fusion surgery for the treatment of spinal deformities that include spinal cord injuries, trauma, degenerative disc disease, and tumors. It stimulates the growth of the bone formation through different stages which include inflammatory, repair, and remodeling. Spine biologics is used in the treatment of symptomatic deformity to achieve successful arthrodesis. Spine biologics is a minimally invasive method and it requires less time as compared to that of open surgical procedures.

Request Free Sample Report @ https://www.zionmarketresearch.com/sample/spine-biologics-market

Global Spine Biologics Market: Growth Factors

Major factors that are driving the spine biologics market growth include rise in the number of geriatric population, benefits provided by spine biologics is faster recovery, minimal postoperative time, and ability to activate cellular growth. Spinal disorders are most common in men and women over 50 years. Spinal injuries can be due to the enlargement of bones & joints, thickening of the band of the tissue, which supports the spine. This is the key factor that is fuelling the market growth in the coming years. People who are at the high risk of spinal deformities need to undergo spinal fusion surgery thus increasing its demand in the global market. However, higher cost of the bone grafts, hostile reimbursement scenario, and concerns regarding the bone grafting procedures is expected to hamper the global spine biologics market growth.

Global Spine Biologics Market: Segmentation

The spine biologics market is segmented on the basis of product, surgery, and region. The product segment is classified into cell based matrix, spinal allografts, platelet rich plasma, and bone graft substitutes. The spinal allografts segment is sub-segmented into demineralized bone matrix and machined bones allograft. The bone graft substitute is sub-segmented into synthetic bone grafts and bone morphogenetic proteins. Depending on the surgery, the market is divided into anterior cervical discectomy and fusion, lateral lumbar interbody fusion, transforamenal lumbar interbody fusion, anterior lumbar interbody fusion, and other surgeries. The region wise breakdown of the market includes North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Request Report TOC (Table of Contents) @ https://www.zionmarketresearch.com/toc/spine-biologics-market

Global Spine Biologics Market: Regional Analysis

North America contributed for the largest market share in the global spine biologics market due to stable economic growth. North America is followed by Europe. Other factors influencing the market are increase in the disposal income, growing population, improved medical literacy, and rising awareness regarding newly developed technologies. Spine biologics has a tremendous demand from the regions of America owing to the advancement in the technology and large pool of the patients. The market in Asia Pacific is experiencing growth in the market owing to increase in the patient pool, advanced rheumatoid arthritis and osteoarthritis procedure, availability of the sophisticated diagnostic technique, and growing awareness among the people. Emerging economies such as China, India, Korea, Thailand, and Vietnam are supporting the market due to economic growth, high prevalence, fast disease progression, improving healthcare facility, and insurance coverage.

Global Spine Biologics Market: Competitive Players

Major companies operating in the global spine biologics market are Exactech, Inc., Alphatec Holdings, Inc., Globus Medical, Depuy Synthes, Inc., and Zimmer Biomet Holdings, Inc. Other prominent players include RTI Surgical, Inc., Medtronic Plc., Xtant Medical., Orthofix International N.V., NuVasive, Inc., Nutech, SeaSpine, and Life Spine, Inc.

Browse detail report @ https://www.zionmarketresearch.com/report/spine-biologics-market

For more information on this press release visit: http://www.sbwire.com/press-releases/spine-biologics-market/release-813720.htm

See the article here:
Global Spine Biologics Market: Size, Trends, Industry Share and Forecast, 2016 2024 - Digital Journal